Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $9.23B.
ENTERPRISE VALUE (EV)
$9.23B
Ionis Pharmaceuticals, Inc.
Market Cap
$7.25B
Enterprise Value (EV)
$9.23B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Ionis Pharmaceuticals, Inc. (IONS) | $7.25B | $9.23B |
| Alkermes plc (ALKS)vs › | $7.04B | $8.10B |
| Hinge Health, Inc. (HNGE)vs › | $7.62B | $7.34B |
| HealthEquity, Inc. (HQY)vs › | $7.63B | $8.35B |
| Cytokinetics, Incorporated (CYTK)vs › | $7.66B | $8.67B |
| Immunovant, Inc. (IMVT)vs › | $6.75B | $5.95B |
| GRAIL Inc. (GRAL)vs › | $6.74B | $6.77B |
| Chemed Corporation (CHE)vs › | $6.68B | $6.97B |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.55B | $7.49B |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | $6.56B |
Market Cap
$7.25B
Total Debt
$2.35B
Cash
$372.26M
Enterprise Value
$9.23B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
